Metronidazole and Probiotics in functional flatulence patients

Phase 2

• Conditions: Abdominal Bloating.; Flatulence; R14.3

• Registration Number: IRCT20220916055971N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Age between 20 and 50 years
Having functional abdominal distention according to the Rome III criteria
The first experience of bloating is more than 6 months before the study
Abdominal bloating feeling at least 3 days a month in the last 3 months
Consent to participate in the study

Exclusion Criteria

Any history of chronic inflammatory disease or structural disease of the gastrointestinal tract
Any serious physical problem or disease such as inflammation or malignancy
?Abnormal laboratory data
Use of Calcium Channel Blocker drugs in the last 3 months
Severe stress in the last 6 months
Positive family history for colon cancer
Pregnancy or breastfeeding\

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Abdominal Bloadting. Timepoint: Before the start of the study, 2 weeks after the start of the study, 4 weeks after the start of the study, 6 weeks after the start of the study and 8 weeks after the start of the study. Method of measurement: Questionnaire for bloating and IBS-QOL questionnaire.